Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Title:
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
Author:
Viale, G. Regan, M.M. Dell'Orto, P. Mastropasqua, M.G. Maiorano, E. Rasmussen, B.B. MacGrogan, G. Forbes, J.F. Paridaens, R.J. Colleoni, M. Láng, I. Thürlimann, B. Mouridsen, H. Mauriac, L. Gelber, R.D. Price, K.N. Goldhirsch, A. Gusterson, B.A. Coates, A.S.